Your email has been successfully added to our mailing list.

×
0.475409836065574 0.475409836065574 0.245901639344262 0.213114754098361 0.147540983606558 0.409836065573771 0.168524590163934 0.0891803278688525
Stock impact report

Cytori Cell Therapy™ Clinical Trial Results in Crohn’s Disease

CYTORI THERAPEUTICS (CYTX) 
Last cytori therapeutics earnings: 11/14 04:15 pm Check Earnings Report
Company Research Source: GlobeNewswire
SAN DIEGO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announces the publication of results from a pilot investigator-initiated clinical trial of Cytori Cell Therapy™ for the treatment of refractory perianal fistula in patients with Crohn’s Disease. These findings were published online this month in the journal Gastroenterology1, a publication of the American Gastroenterological Association. Highlighted results from this study: 10 patients were treated with a single administration of Cytori Cell Therapy™. No significant safety concerns were noted as part of the therapy.80% of patients exhibited a clinical response at 48 weeks; 60% of patients were deemed in combined remission with no evidence of leakage by clinical examination or MRI.76% of treated external fistula openings showed complete re-epithelialization or an absence of drainage at week 4850% decrease in mean Perianal Crohn’s Disease Activity Index (PDAI) 2 at 48 weeks (7.3 points at baseline Show less Read more
Impact Snapshot
Event Time:
CYTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CYTX alerts
Opt-in for
CYTX alerts

from News Quantified
Opt-in for
CYTX alerts

from News Quantified